Northwestern University
United States
His primary areas of investigation include Internal medicine, Pathology, Cancer research, Immunology and Platelet. The study incorporates disciplines such as Gastroenterology and Endocrinology in addition to Internal medicine. His studies deal with areas such as Microcirculation, In vitro, Hemorheology and Hyperviscosity syndrome as well as Pathology.
His work deals with themes such as Cancer, Metastasis, Tissue factor, Urokinase receptor and Fibrinolysis, which intersect with Cancer research. His research integrates issues of Acute promyelocytic leukemia and Disseminated intravascular coagulation in his study of Immunology. His Platelet research is multidisciplinary, incorporating elements of Diagnostico diferencial, Pathophysiology and Plasmapheresis.
His scientific interests lie mostly in Internal medicine, Immunology, Pathology, Fibrinolysis and Surgery. His Internal medicine research is multidisciplinary, incorporating perspectives in Gastroenterology and Endocrinology. His Immunology research integrates issues from Acute promyelocytic leukemia, Disseminated intravascular coagulation and Tissue factor.
His Fibrinolysis study combines topics in areas such as Plasminogen activator, Tissue plasminogen activator, Bioinformatics and Fibrin. His Plasminogen activator research is multidisciplinary, relying on both Molecular biology, Cancer research, Plasmin and Urokinase. In his study, Coagulopathy is strongly linked to Intensive care medicine, which falls under the umbrella field of Thrombosis.
Hau C. Kwaan mostly deals with Internal medicine, Immunology, Thrombosis, Intensive care medicine and Acute promyelocytic leukemia. His Internal medicine research incorporates elements of Gastroenterology and Oncology. The concepts of his Immunology study are interwoven with issues in Apoptosis, Fibrinolysis, Cumulative incidence and Hazard ratio.
Hau C. Kwaan has included themes like Plasminogen activator, Tissue plasminogen activator and Bioinformatics in his Fibrinolysis study. His research on Thrombosis also deals with topics like
His primary areas of study are Immunology, Internal medicine, Acute promyelocytic leukemia, Coagulopathy and Intensive care medicine. His Immunology study combines topics from a wide range of disciplines, such as Hemostasis, Fibrinolysis and Tissue plasminogen activator. His Fibrinolysis study incorporates themes from Transmission, Lung pathology and Plasmin.
His Tissue plasminogen activator research also works with subjects such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases
Charles L. Bennett;Peter D. Weinberg;Karine Rozenberg-Ben-Dror;Karine Rozenberg-Ben-Dror;Paul R. Yarnold.
Annals of Internal Medicine (1998)
Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.
Leo R. Zacharski;William G. Henderson;Frederick R. Rickles;Walter B. Forman.
Cancer (1984)
Reassessing the hemostatic disorder associated with acute promyelocytic leukemia.
Martin S. Tallman;Hau C. Kwaan.
Blood (1992)
Increased platelet aggregation in diabetes mellitus.
H C Kwaan;J A Colwell;J A Colwell;J A Colwell;S Cruz;S Cruz;S Cruz;N Suwanwela;N Suwanwela;N Suwanwela.
Journal of Laboratory and Clinical Medicine (1972)
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
Stephen Gately;Przemyslaw Twardowski;M. Sharon Stack;Deborah L. Cundiff.
Proceedings of the National Academy of Sciences of the United States of America (1997)
Effect of Warfarin on Survival in Small Cell Carcinoma of the Lung: Veterans Administration Study No. 75
Leo R. Zacharski;William G. Henderson;Frederick R. Rickles;Walter B. Forman.
JAMA (1981)
Human Prostate Carcinoma Cells Express Enzymatic Activity That Converts Human Plasminogen to the Angiogenesis Inhibitor, Angiostatin
Stephen Gately;Przemyslaw Twardowski;M. Sharon Stack;Matthew Patrick.
Cancer Research (1996)
The plasminogen-plasmin system in malignancy
Hau C. Kwaan.
Cancer and Metastasis Reviews (1992)
Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.
Gerald A. Soff;Judith Sanderowitz;Stephen Gately;Elaine Verrusio.
Journal of Clinical Investigation (1995)
Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study
Maria B. Bernik;Hau C. Kwaan.
Journal of Clinical Investigation (1969)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
United States Department of Veterans Affairs
Memorial Sloan Kettering Cancer Center
Duke University
Instituto de Salud Carlos III
University of Freiburg
Texas Medical Center
Northwestern University
St. Jude Children's Research Hospital
Northwestern University
Erasmus MC
Harvard University
Yuan Ze University
Indian Institute of Technology Delhi
Shaanxi Normal University
Harvard University
University of Connecticut Health Center
National Autonomous University of Mexico
University of Pennsylvania
Friedrich-Loeffler-Institut
North Carolina State University
Chinese Academy of Sciences
Max Planck Institute for Chemistry
The Ohio State University
Vrije Universiteit Amsterdam
University of Miami
City University of New York